drugset / Trial / NCT01481233

Oral Colchicine in Men With Castrate Resistant Prostate Cancer

NCT01481233 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the prostate specific antigen response to continuous low dose oral colchicine.

Timeline

Start
2013-05
Primary completion
2013-08
Completion
2013-08

Outcome

Outcome not reported

Stopped (Business): “Due to funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral

Indications